Investigation on maintenance hemodialysis patients with mineral and bone disorder in Anhui province, China

被引:1
|
作者
Tao, Shuman [1 ]
Li, Xiuyong [2 ]
Liu, Zhi [3 ]
Bai, Youwei [4 ]
Qian, Guangrong [5 ]
Wu, Han [6 ]
Li, Ji [7 ]
Guo, Yuwen [8 ]
Yang, Shanfei [9 ]
Chen, Lei [10 ]
Yang, Jian [11 ]
Han, Jiuhuai [12 ]
Ma, Shengyin [13 ]
Yang, Jing [14 ]
Yu, Linfei [15 ]
Shui, Runzhi [16 ]
Jin, Xiping [17 ]
Wang, Hongyu [18 ]
Zhang, Fan [19 ]
Chen, Tianhao [20 ]
Li, Xinke [21 ]
Zong, Xiaoying [22 ]
Liu, Li [23 ]
Fan, Jihui [24 ]
Wang, Wei [25 ]
Zhang, Yong [26 ]
Shi, Guangcai [27 ]
Wang, Deguang [1 ]
机构
[1] Anhui Med Univ, Dept Nephrol, Hosp 2, 678 Furong Rd, Hefei 230601, Peoples R China
[2] 2 Peoples Hosp Fuyang City, Blood Purificat Ctr, 1088 Yinghe West Rd, Fuyang 236015, Peoples R China
[3] Anhui Univ Sci & Technol, Dept Nephrol, Affiliated Hosp 1, 203 Huaibin Rd, Huainan 232000, Peoples R China
[4] Second Peoples Hosp Luan City, Dept Nephrol, 73 Mozitan Rd, Luan 237000, Peoples R China
[5] Maanshan Peoples Hosp, Dept Nephrol, 45 Hubei Rd, Maanshan 243099, Peoples R China
[6] Bozhou Peoples Hosp, Blood Purificat Ctr, 616 Duzhong Rd, Bozhou 236814, Peoples R China
[7] Tongling Peoples Hosp, Dept Nephrol, 468 Bijiashan Rd, Tongling 244099, Peoples R China
[8] Lujiang Cty Peoples Hosp, Dept Nephrol, 32 Wenmingzhong Rd, Lujiang 231501, Peoples R China
[9] Shouxian Cty Hosp, Dept Nephrol, Northeast Intersect Binyang Ave & Dongjin Ave, Huainan 232200, Shouxian County, Peoples R China
[10] Hefei Jinnan Kidney Hosp, Dept Nephrol, Northeast Intersect Fozhang Rd & Beihai Rd, Hefei 230071, Peoples R China
[11] Funan Cty Peoples Hosp, Dept Nephrol, 36 Santa Rd, Fuyang 236300, Funan County, Peoples R China
[12] Anqing Municipal Hosp, Dept Nephrol, 87 East Tianzhushan Rd, Anqing 246003, Peoples R China
[13] Anhui Wanbei Coal Elect Grp Gen Hosp, Dept Nephrol, 125 Huaihe West Rd, Suzhou 234099, Peoples R China
[14] First Peoples Hosp Hefei, Dept Nephrol, 390 Huaihe Rd, Hefei 230061, Peoples R China
[15] Peoples Hosp Taihu, Dept Nephrol, 196 Renmin Rd, Anqing 246400, Taihu County, Peoples R China
[16] Huangshan City Peoples Hosp, Blood Purificat Ctr, 4 Liyuan Rd, Huangshan 245000, Peoples R China
[17] Huainan Chao Yang Hosp, Dept Nephrol, 15 Renmin South Rd, Huainan 232007, Peoples R China
[18] Lixin Cty Peoples Hosp, Dept Nephrol, Intersect Wenzhou Rd & Feihe Rd, Bozhou 236700, Lixin County, Peoples R China
[19] Dongzhi Cty Peoples Hosp, Dept Nephrol, 70 Jianshe Rd, Chizhou 247299, Dongzhi County, Peoples R China
[20] Tianchang City Peoples Hosp, Dept Nephrol, 137 Jianshe East Rd, Tianchang 239399, Peoples R China
[21] Xiaoxian Peoples Hosp, Dept Nephrol, 58 Jiankang Rd, Suzhou 235200, Xiaoxian County, Peoples R China
[22] Bengbu Med Coll, Dept Nephrol, Affiliated Hosp 2, 633 Longhua Rd, Bengbu 233017, Peoples R China
[23] Second Peoples Hosp Hefei, Dept Nephrol, 246 Heping Rd, Hefei 230012, Peoples R China
[24] Huaibei Peoples Hosp, Dept Nephrol, 66 Huaihai West Rd, Huaibei 235000, Peoples R China
[25] Peoples Hosp Xuancheng City, Dept Nephrol, 51 Dabatang Rd, Xuancheng 242099, Peoples R China
[26] Lujiang Cty Hosp TCM, Dept Nephrol, 350 Zhouyu Ave, Lucheng Town 231501, Lujiang County, Peoples R China
[27] Fifth Peoples Hosp Hefei, Dept Nephrol, Yuxi Rd, Hefei 230011, Peoples R China
关键词
Chronic kidney disease; Hemodialysis; Mineral and bone disorder; 10-YEAR OUTCOMES; KIDNEY-DISEASE; PHOSPHATE; RISK; ASSOCIATION; MORTALITY; MARKERS; CALCIUM; DEATH;
D O I
10.1007/s11255-022-03328-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Chronic kidney disease-mineral bone disorder (CKD-MBD) is a common comorbidity in patients with CKD. The study aims to describe the control rates of serum-corrected calcium (Ca), phosphate (P) and intact parathyroid hormone (iPTH) and its risk factors among maintenance hemodialysis (MHD) patients in Anhui Province of China. Methods The study was conducted in 27 hemodialysis centers of Anhui Province between January 1st 2020 and December 31th 2020. Chi-square test was used to compare the control rates of serum-corrected Ca, P and iPTH between the present study and DOPPS 4 or Anhui Province in 2014. Binary logistic regression analysis was used to explore the risk factors of the control rates of serum-corrected Ca, P and iPTH. Results A total of 3 025 MHD patients were recruited in this study, with a mean age of 54.8 (SD: 12.8) years, and 60.1% were males. According to the Chinese Diagnosis and Treatment Guidelines for CKD-MBD, the control rates of serum-corrected Ca, P and iPTH in the present study were 57.9%, 20.0% and 56.0%, respectively. Based on KDOQI guidelines (2003), the control rates of the above indicators were 43.1%, 35.3% and 22.3%, respectively. The control rates of serum-corrected Ca, P and iPTH in this study were lower than those of DOPPS 4 (P < 0.001). Compared to the results of Anhui Province in 2014, the control rate of corrected Ca was higher (P < 0.001) and the control rate of iPTH was lower (P = 0.005). Age, residential area, BMI, dialysis vintage, albumin and hemoglobin levels were factors of serum-corrected Ca, P and iPTH not within target range. Conclusion The control rates of serum-corrected Ca, P and iPTH in MHD patients in Anhui Province are relatively low. Monitoring and management should be strengthened to improve the prognosis of patients undergoing dialysis.
引用
收藏
页码:389 / 398
页数:10
相关论文
共 50 条
  • [1] Investigation on maintenance hemodialysis patients with mineral and bone disorder in Anhui province, China
    Shuman Tao
    Xiuyong Li
    Zhi Liu
    Youwei Bai
    Guangrong Qian
    Han Wu
    Ji Li
    Yuwen Guo
    Shanfei Yang
    Lei Chen
    Jian Yang
    Jiuhuai Han
    Shengyin Ma
    Jing Yang
    Linfei Yu
    Runzhi Shui
    Xiping Jin
    Hongyu Wang
    Fan Zhang
    Tianhao Chen
    Xinke Li
    Xiaoying Zong
    Li Liu
    Jihui Fan
    Wei Wang
    Yong Zhang
    Guangcai Shi
    Deguang Wang
    International Urology and Nephrology, 2023, 55 : 389 - 398
  • [2] Refining the definition of clinically important mineral and bone disorder in hemodialysis patients
    Danese, Mark D.
    Halperin, Marc
    Lowe, Kimberly A.
    Bradbury, Brian D.
    Do, Thy P.
    Block, Geoffrey A.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 (08) : 1336 - 1344
  • [3] Clinical Characteristics of Patients with Diabetic Nephropathy on Maintenance Hemodialysis: A Multicenter Cross-sectional Survey in Anhui Province, Eastern China
    Chen, Hu
    Wang, De-Guang
    Yuan, Liang
    Liu, Gui-Ling
    He, Heng-Jie
    Wang, Juan
    Zhang, Sen
    Hao, Li
    CHINESE MEDICAL JOURNAL, 2016, 129 (11) : 1291 - 1297
  • [4] Association of serum alkaline phosphatase and bone mineral density in maintenance hemodialysis patients
    Park, Jong Chan
    Kovesdy, Csaba P.
    Duong, Uyen
    Streja, Elani
    Rambod, Mehdi
    Nissenson, Allen R.
    Sprague, Stuart M.
    Kalantar-Zadeh, Kamyar
    HEMODIALYSIS INTERNATIONAL, 2010, 14 (02) : 182 - 192
  • [5] Mineral bone disorder and osteoporosis in hemodialysis patients
    Slouma, Maroua
    Sahli, Hela
    Bahlous, Afef
    Laadhar, Lilia
    Smaoui, Wided
    Rekik, Sonia
    Gharsallah, Imen
    Sallami, Meriem
    Ben Moussa, Fatma
    Elleuch, Mohamed
    Cheour, Elhem
    ADVANCES IN RHEUMATOLOGY, 2020, 60 (01)
  • [6] Mineral and bone disorder management in hemodialysis patients: comparing PTH control practices in Japan with Europe and North America: the Dialysis Outcomes and Practice Patterns Study (DOPPS)
    Yamamoto, Suguru
    Karaboyas, Angelo
    Komaba, Hirotaka
    Taniguchi, Masatomo
    Nomura, Takanobu
    Bieber, Brian A.
    De Sequera, Patricia
    Christensson, Anders
    Pisoni, Ronald L.
    Robinson, Bruce M.
    Fukagawa, Masafumi
    BMC NEPHROLOGY, 2018, 19
  • [7] Mineral and bone disorder in Chinese dialysis patients: a multicenter study
    Kong, Xianglei
    Zhang, Luxia
    Zhang, Ling
    Chen, Nan
    Gu, Yong
    Yu, Xueqing
    Liu, Wenhu
    Chen, Jianghua
    Peng, Liren
    Yuan, Weijie
    Wu, Hua
    Chen, Wei
    Fan, Minhua
    He, Liqun
    Ding, Feng
    Chen, Xiangmei
    Xiong, Zuying
    Zhang, Jinyuan
    Jia, Qiang
    Shi, Wei
    Xing, Changying
    Tang, Xiaoling
    Hou, Fanfan
    Shu, Guiyang
    Mei, Changlin
    Wang, Li
    Xu, Dongmei
    Ni, Zhaohui
    Zuo, Li
    Wang, Mei
    Wang, Haiyan
    BMC NEPHROLOGY, 2012, 13
  • [8] Epidemiology investigation and analysis of patients with hemodialysis in Sichuan province of China
    Zou, Yang
    Hong, Daqing
    He, Qiang
    Wen, Yu
    Li, Guisen
    RENAL FAILURE, 2019, 41 (01) : 644 - 649
  • [9] Real World Use and Effects of Calcimimetics in Treating Mineral and Bone Disorder in Hemodialysis Patients
    Danese, Mark D.
    Lubeck, Deborah
    Belozeroff, Vasily
    Lin, Tzu-Chieh
    Desai, Pooja
    Gleeson, Michelle
    Martin, Kevin
    Chonchol, Michel
    AMERICAN JOURNAL OF NEPHROLOGY, 2020, 51 (10) : 815 - 822
  • [10] Serum Osteoprotegerin Level Is Negatively Associated with Bone Mineral Density in Patients Undergoing Maintenance Hemodialysis
    Lu, Chia-Wen
    Wang, Chih-Hsien
    Hsu, Bang-Gee
    Tsai, Jen-Pi
    MEDICINA-LITHUANIA, 2021, 57 (08):